Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Again Looks Outside Generic Drugs Office For New Director

Feb 12 2019

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Generics Office At US FDA Could Get New Director Before Uhl Departs

Jul 19 2018

FDA Generics Office Gets Third Director In Three Workdays; Uhl Brings Policy, Pharmacology Experience

Mar 20 2013

FDA’s Generics Office Loses Another Director As Geba Makes Quick Exit

Mar 14 2013

US FDA's Generics Program Reaches 'Steady State' Milestone

Sep 07 2018

Combination Products: US FDA Aims For Limited Two-Application Solutions

Feb 12 2019

Generic Advair's Labeling Variation Stems From Permissible Design Differences, US FDA Says

Feb 11 2019

Biosimilar Template Revisited: Inflectra Approval Binds And Separates From Remicade

Apr 06 2016

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

Generic Drugs Gain Status Boost Within CDER

Sep 07 2012

Related Companies

Parexel International Corp.

Celltrion, Inc.

Pfizer Inc.

Bristol Myers Squibb Company

Sanofi

GSK plc

Additional Topics

United States Generic Drugs FDA Regulation Leadership BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window